Rebif is a brand-name liquid solution that’s typically self-injected. It’s prescribed for certain forms of multiple sclerosis (MS) and contains the active ingredient interferon beta-1a. It is not ...
Rebif is used to treat multiple sclerosis and clinically isolated syndrome. It can interact with certain monoclonal antibodies like alemtuzumab and ozanimod, increasing the risk of infection. Drinking ...
FRANKFURT, Feb 6 (Reuters) - German Merck KGaA said on Tuesday a U.S. regulator has asked for more data on a new formulation of its multiple sclerosis drug Rebif, a move that could delay approval for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results